Impact of intense, longitudinal retreatment with praziquantel on cure rates of schistosomiasis mansoni in a cohort of occupationally exposed adults in western Kenya-Reference-Cited by-同舟云学术

Impact of intense, longitudinal retreatment with praziquantel on cure rates of schistosomiasis mansoni in a cohort of occupationally exposed adults in western Kenya

Published:2009-04 Issue:4 Volume:14 Page:450-457
ISSN:1360-2276
Container-title:Tropical Medicine & International Health
language:en
Short-container-title:

Author:

Black Carla L.,Steinauer Michelle L.,Mwinzi Pauline N. M.,Evan Secor W.,Karanja Diana M. S.,Colley Daniel G.

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,Parasitology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-3156.2009.02234.x/fullpdf

Reference26 articles.

1. Current status of sensitivity to praziquantel in a focus of potential drug resistance in Egypt;Botros;International Journal of Parasitology,2005

2. The chemotherapeutic effect of praziquantel against Schistosoma mansoni is dependent on host antibody response;Brindley;Journal of Immunology,1987

3. The global status of schistosomiasis and its control;Chitsulo;Acta Tropica,2007

4. Praziquantel: is there real resistance and are there alternatives?;Cioli;Current Opinion in Infectious Diseases,2000

5. Evidence for an immune-dependent action of praziquantel on Schistosoma mansoni in mice;Doenhoff;Transactions of the Royal Society of Tropical Medicine and Hygiene,1987

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of single-dose artesunate plus sulfalene/pyrimethamine combined with praziquantel for the treatment of children with Schistosoma mansoni or Schistosoma haematobium in western Kenya: a randomised, open-label controlled trial;Parasites & Vectors;2024-06-28

2. Efficacy and safety of single-dose artesunate plus sulfalene/pyrimethamine combined with praziquantel for the treatment of children with Schistosoma mansoni or Schistosoma haematobium in western Kenya: a randomised, open-label controlled trial;2024-01-23

3. Efficacy and safety of praziquantel plus Artemisinin-based combinations in the treatment of Kenyan children withSchistosoma mansoniinfection: an open-label, randomized, head-to-head, non-inferiority (SCHISTOACT) trial;2024-01-13

4. SCHISTOACT: a protocol for an open-label, five-arm, non-inferiority, individually randomized controlled trial of the efficacy and safety of praziquantel plus artemisinin-based combinations in the treatment of Schistosoma mansoni infection;Trials;2023-11-27

5. Trained immunity: a cutting edge approach for designing novel vaccines against parasitic diseases?;Frontiers in Immunology;2023-10-06